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SignalingPhosphatidylinositol-4 kinase (PI-4K) is responsible for the generation of phosphatidylinositol-4 phosphate
(PtdIns(4)P), a bioactive signaling molecule involved in several biological functions. In this study, we show that
sphingosine modulates the activity of the PI-4K isoform associated with the basolateral membranes (BLM) from
kidney proximal tubules. Immunoblottingwith an anti-α subunit PI-4K polyclonal antibody revealed the presence
of two bands of 57 and 62 kDa in the BLM. BLM-PI-4K activity retains noteworthy biochemical properties; it is
adenosine-sensitive, not altered by wortmanin, and signiﬁcantly inhibited by Ca2+ at the μM range. Together,
these observations indicate the presence of a type II PI-4K. Endogenous phosphatidylinositol (PI) alone reaches
PI-4K half-maximal activity, revealing that even slight modiﬁcations in PI levels at the membrane environment
promote signiﬁcant variations in BLM-associated-PI-4K activity. ATP-dependence assays suggested that the
Mg.ATP2− complex is the true substrate of the enzyme and that free Mg2+ is an essential cofactor. Another obser-
vation indicated that higher concentrations of free ATP are inhibitory. BLM-associated-PI-4K activity was ~3-fold
stimulated in the presence of increasing concentration of sphingosine, while in concentrations higher than
0.4 mM, inwhich S1P is pronouncedly formed, therewas an inhibitory effect on PtdIns(4)P formation.We propose
that a tightly coupled regulatory network involving phosphoinositides and sphingolipids participate in the regula-
tion of key physiological processes in renal BLM carried out by PI-4K.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Membrane phospholipids participate in a variety of cellular processes.
They establish a hydrophobic barrier, provide a matrix for catalytic pro-
cesses and inﬂuence the functional properties of membrane-associated
events [1]. It is also well documented that plasma membrane lipids are
implicated in signal transduction events in response to extracellular stim-
uli. Phosphatidylinositol (PtdIns) and other inositol-containing lipids
(phosphoinositides) represent a small fraction of the total glycerolipids
present in all cellular membranes. These phosphoinositides are known
to regulate distinct cell signaling pathways, which in turn modulate
important cell functions such as proliferation, differentiation, membraneM-PI4K, phosphatidylinositol-4
erol; DGK, diacylglycerol kinase;
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ights reserved.trafﬁcking and cytoskeletal organization [2,3]. Receptor-stimulated
phosphoinositide turnover has drawn much attention from re-
searchers for over 50 years, since a striking increase in 32P-labeling
in both PtdIns and phosphatidic acid (PA) was observed after cell
stimulation [4]. The synthesis, degradation, and subsequent resyn-
thesis of the phosphoinositides form a crucial cellular metabolic
cycle known as the phosphoinositide cycle, and whose proper function
is required for cell viability [5,6]. A primary step in the synthesis of the dif-
ferent phosphoinositides is the phosphorylation of PtdIns at the D4 posi-
tion of the inositol ring. This produces phosphatidylinositol-4 phosphate
(PtdIns(4)P), which is the substrate for another phosphoinositide kinase
that catalyzes the phosphorylation of PtdIns(4)P in the D5 position and
yields phosphatidylinositol-4,5 bisphosphate (PtdIns(4,5)P2).
PtdIns(4,5)P2 is further converted by phospholipase C (PLC) into two
secondmessengers, namely, inositol 1,4,5-trisphosphate (IP3) and diacyl-
glycerol (DAG). The discovery of this step was a major breakthrough in
phosphoinositide metabolism due to its importance in the activation of
intracellular Ca2+ transients through receptor-stimulated events. The hy-
drophilic headgroup IP3 also mobilizes Ca2+ from internal stores while
the hydrophobic backbone DAG activates protein kinase C (PKC) and ini-
tiates a variety of Ca2+-dependent, lipid-dependent cell responses [6–8].
In the last twenty years, it has become clear that phosphoinositides
act asmore than secondmessenger precursors. For instance, PtdIns(4)P
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[9–11] and ion channels [12], which suggests that this acidic phospho-
lipid is a direct modulator of Ca2+ homeostasis and perhaps even
most of the Ca2 +-dependent cell functions. Thus, enzymes that phos-
phorylate PtdIns on the D4 position of the inositol ring, which are re-
ferred to as PtdIns-4 kinases (PI-4K), now are critical components of
cell biology metabolism [13].
PI-4Ks have two major classiﬁcations based on their catalytic prop-
erties [14]. The type II enzymes are membrane-bound proteins that
have been puriﬁed from different sources with molecular weights in
the range of 55–60 kDa. They have a high afﬁnity for ATP (Km in the
10–50 μM range) and thus high sensitivity to inhibition by adenosine
(Ki in the 10–100 μM range) [14]. Their activity is greatly stimulated
by detergents, requires Mg2+ (or Mn2+) and is inhibited in the
presence of micromolar concentrations of Ca2+ (for review see
[14–16]). On the other hand, type III PI-4K are larger proteins with mo-
lecular weights ranging from 90 to 230 KDa. They have low afﬁnity for
ATP (Km in the 400–800 μM range), low sensitivity to adenosine (Ki
above 1 mM) and are not commonly associated to membranes [3,14].
The type I PtdIns kinase refers to the PI-3 K family [17–19].
Basolateral membranes (BLM) from kidney proximal tubules
constitute an interesting model for the study of phosphoinositide
turnover and its physiological roles, because they preserve a variety
of different enzymes and receptors involved with this process, in-
cluding surface receptors, trimeric G-proteins, protein kinases, phos-
pholipases and different ion transporters [20–22]. Previous results
from our laboratory demonstrated the formation of PtdIns(4)P in
phosphorylation assays of puriﬁed BLM from pig kidney [11,23,24].
The results indicated the presence of a mechanism involved in the
metabolism of phosphoinositides and suggested that this signaling
lipid is involved in the regulatory network associated with this mem-
brane. In addition, we demonstrated the existence of crosstalk be-
tween phosphoinositides and sphingolipid metabolism, suggesting
their potential involvement in the regulation of kidney BLM func-
tions [23].
Themain goal of this paper is to describe the inﬂuence of sphingolipid
metabolism on BLM-associated-PI-4K activity, and to better characterize
the biochemical properties of this enzyme. Both bioactive lipid clas-
ses (phosphoinositides and sphingolipids) have important roles in
transepithelial ion ﬂuxes by locally controlling the levels of impor-
tant lipid mediators such as PtdIns(4)P, diacylglycerol (DAG) and
sphingosine-1 phosphate (S1P), which further modulate the ion
pumps and other transporters based on the BLM [20–22].
2. Material and methods
2.1. Material
Buffers, bovine serumalbumin and protease inhibitorswere obtained
from Sigma Chemical Co. (Saint Louis, MO). Percoll was from Pharmacia
(Uppsala, Sweden). Thin layer chromatography (TLC) plates and all the
reagents used in the chromatographic procedures were provided by
Merck (Darmstaadt, Germany). All the solutions and ﬁlms used in auto-
radiogramswere fromKodak (Resende, Brazil). Distilledwater deionized
with the Milli-Q system of resins (Millipore Corp., Marlborough, MA)
was used to prepare all solutions. [32Pi]Pi was obtained from IPEN (São
Paulo, Brazil). [γ-32P]ATP was prepared as described [25]. The antibody
anti-PI-4Kα-subunit was purchased from Santa Cruz Research Antibod-
ies (Santa Cruz, CA). All the reagents used for SDS-PAGE and the nitrocel-
lulose membranes, ECL kit and hyperﬁlm used for the immunoblotting
assay were provided by Amersham Bioscience (Buckinghamshire, UK).
Pig kidneys were obtained from a slaughterhouse that operates
under the supervision of licensed veterinarians. Kidneys were promptly
removed after the animals had been killed, and transported in a chilled
solution containing 250 mM sucrose, 10 mM Hepes-Tris (pH 7.6),
2 mM EDTA, 1 mM PMSF, and 0.15 mg/ml of soybean trypsin inhibitor.The external portion of the cortex was carefully removed and immedi-
ately used for membrane preparation.
2.2. Isolation of basolateral membranes
Puriﬁed basolateral membranes derived from kidney proximal tu-
bules were prepared using the Percoll gradient method [26]. Controls
for contamination with other membranes were carried out as previous-
ly described [20,27]. The speciﬁc activity of the basolateral membrane
marker (Na+ + K+)ATPase (163,8 ± 1.3 nmol × mg−1 × min−1)
was enriched six-fold when compared to that measured in the starting
kidney cortex homogenate (not shown). Themembraneswere stored in
250 mM sucrose in liquid N2, which preserved marker activity for at
least 5 months.
2.3. Phosphorylation assay
We used the procedure previously described [11,23,24] with slight
modiﬁcations. Exceptwhenotherwise noted, the standard assaymedium
(1 ml) contained 30 mMMES-Tris (pH 7.0), 1 mM [γ-32P]ATP (speciﬁc
activity 105 cpm/nmol), 1.1 mM MgCl2 or 1 mM EDTA for Mg2+-free
conditions, 10 mM NaN3, 0.5 mM ouabain, and 0.5 mM EGTA. The reac-
tionwas started by the addition of [γ-32P]ATP to themembranes (0.1 mg
protein/ml) and the incubation time was 10 min at 37 °C. Except when
noted, the substances to be tested under each experimental condition
were added immediately before addition of [γ-32P]ATP.
2.4. Lipid analysis
Total lipids were extracted by adding 5 ml of chloroform/methanol/
HCl (2:1:0.075, v/v) as described in [28] after incubation of the mem-
branes. The resulting organic phase was dried under N2, reconstituted
in 90 μl of chloroform/methanol/H2O (7.5:2.5:0.2 v/v), and spotted onto
heat-activated silica-gel 60 TLC plates. The plates were developed in
chloroform/acetone/methanol/acetic acid/water (120:45:39:36:24, v/v),
and the lipids that were phosphorylated by [γ-32P]ATP were detected in
the autoradiograms of the TLC plates as described elsewhere [11,23,24].
2.5. Measurement of phosphatidylinositol-4 kinase activity
The PtdIns(4)32P spots detected by autoradiography were scraped
from the TLC plate, put in a vial and counted in a liquid scintillation coun-
ter. The activity was expressed as pmol PtdIns(4)P × mg−1 × min−1.
2.6. Determination of free ATP and the MgATP2−complex concentrations
Free ATP and MgATP2−at different ATP and MgCl2 concentrations
were calculated using software that took into account the different spe-
cies involved in the equilibria between EGTA, contaminant Ca2+
(10 μM), ATP, Mg2+ and H+, and the inﬂuence of ionic strength on
the association constants for ATP and Mg2+ [29].
2.7. Protein determination assay
A 10 μl aliquot (in triplicate) was used for the protein determination
assay, which was performed using the Folin phenol method described
by Lowry et al. [30] with the addition of 5% SDS in the samples, and
bovine serum albumin as standard.
2.8. SDS-PAGE and immunoblotting
The BLM fractionswere solubilized in a small volume of sample buff-
er to a ﬁnal concentration of 2 μg/μl. The maximal volume/slot was
50 μl. The total BLM proteinswere separated and identiﬁed in 12.5% so-
dium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
using a Mini PROTEAN®3 System (Bio-Rad Laboratories, Hércules, CA)
Fig. 1. Evidence for the presence of a PI-4K type II in BLM fromkidney proximal tubules. A, left panel. Autoradiogramof a TLC plate showing that only PtdIns(4)32P and 32PA are formed in a
Mg2+-dependent fashion after the phosphorylation assay carried out as described in Section 2 [24]. A, right panel. Immunoblotting detection of the PI-4K type IIα-subunit. Total proteins
from BLM fraction were separated by SDS-PAGE (10% gel) and PI-4K was further identiﬁed by immunoblotting as described in Section 2.8, using aliquots of 75 or 100 μg BLM protein as
indicated. BLM = basolateral membranes; RC = rat cerebellum. B. Adenosine-sensitivity of BLM-PI-4K activity. The activity was assayed at 120 μM ATP in the absence (black bar) or
presence (gray bar) of 100 μM adenosine. Results express means ± SEM from different experiments done in triplicate (n = 5). * Statistically signiﬁcant with p b 0,05. C. BLM-
associated-PI-4K activity was insensitive to wortmannin (Wtm). BLM-associated-PI-4K activity was performed as described in Section 2.5, in the absence or presence of different concen-
trations of Wtm, as shown in the abscissa. NS = not statistically signiﬁcant. D. The BLM-associated-PI-4K activity was signiﬁcantly inhibited by high Ca2+ concentrations (mM range).
BLM-associated-PI-4K activitywasperformed as described in Section 2.5, in the absence or presence of different concentrations of free Ca2+, as shown in the abscissa. Results are expressed
as means ± SEM from different experiments done in triplicate (n = 5). * Statistically different (p b 0,05).
1 PtdIns(4,5)P2 is detected at highest speciﬁc activity (1011 cpm/nmol) [31].
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nitrocellulose membrane (Amersham Bioscience, Uppsala, Sweden)
using the same Bio-Rad system described above for approximately
90 min. The nitrocellulose membrane containing the immobilized pro-
teins was ﬁrst blocked with non-fat dry milk (5%) plus BSA (1%) in Tris
buffered saline containing Tween (0.1%) (TBS-T), for 90 min. After the
blockage, themembranewaswashed twice in TBS-T under constant stir-
ring for 3 min. Next, the membrane was incubated with the polyclonal
antibody anti-PI-4K α-subunit (1:300) under constant stirring for 2 h
at room temperature. The membrane was washed again (ﬁve times,
3 min each) with TBS-T. The secondary antibody used was an anti-
mouse HRP (1:2000) which was incubated with the membrane for
90 min at room temperature under constant stirring with a sequential
wash (ﬁve times, 3 min each) with TBS-T. The PI-4K was detected
using the chemiluminescence ECL™ system and Hyperﬁlm. Themolecu-
lar weight was determined by using pre-stained molecular weight
standards.
2.9. Statistical analysis
The results were expressed as means ± SEM of at least three sepa-
rate determinations that were performed in triplicate with different
membrane preparations. Where appropriate, data was compared by
analysis of variance (ANOVA) using the statistical software package
SPSS 8.0.
3. Results
3.1. BLM-associated-PI-4K identiﬁcation and activity
Prior observations from our group reported the detection of a PI-4K
activity associated to the BLM from kidney proximal tubule cells[11,23,24]. Here we explored the main requirements for the BLM-
associated-PI-4K activity in order to provide evidence that the enzyme
in question is a type II PI-4K. Fig. 1A (left panel) shows the formation of
PtdIns(4)32P, after pre-incubation of the BLM fraction in the presence of
[γ-32P]ATP, followed by lipid extraction and separation by TLC as
described in the Methods section of this paper. In spite of the presence
of different phospholipids revealed after the exposure of the TLC plates
to iodine vapors (data not shown), only two phospholipids were signiﬁ-
cantly labeled with the use of a speciﬁc activity of 105 cpm/nmol
[γ-32P]ATP,1 as revealed by the autoradiogram of the respective TLC
plate: PtdIns(4)32P and 32P-PA (see also [24]). The left panel for Fig. 1A
also shows that the PI-4K activity was completely abolished when
Mg2+ was removed from the reaction medium. The presence of a PI-4K
associated with the BLM was further conﬁrmed by immunoblotting
with the use of a polyclonal antibody anti-PI-4Kα-subunit, which recog-
nizes different PI-4Kα-subunits. Fig. 1A (right panel) reveals that the an-
tibody recognized two main bands at≈57 and 62 kDa, which are also
present in rat cerebellum (RC), used here as a positive control, and corre-
spond to the type II PI-4K α-subunit. It is also possible to observe other
weakly detected bands of higher molecular weight suggesting the exis-
tence of other PI-4K isoforms in the BLM.3.2. BLM-associated-PI-4K features
The lowmolecular weight detected after immunoblotting suggested
that the BLM-associated-PI-4K activity should be ascribed as a type II
enzyme. Supplementary Figures show basic assays that attempt to
standardize the preferred conditions under which to measure the
Fig. 2. Substrates-dependency for the BLM-associated-PI-4K activity. A. The BLM-PI-4K ac-
tivity was performed as described in Section 2.5, without (black bar) and with (gray bars)
exogenous PtdIns at 50 or 500 nM, as depicted in the abscissa. Results are expressed as
mean ± SEM of four different experiments done in triplicate. B. Correlation between the
Mg.ATP2- complex formation according to addition of increased Mg2+ and the raise in the
BLM-associated-PI-4K activity. PtdIns(4)P formation increases according to the augment
in Mg2+ up to 15 mM (main panel). The increase in the BLM-associated-PI-4K activity
is simultaneously to the formation of the Mg.ATP2- complex (see dashed line in the
inset), while it reaches a plateau concomitantly to the consumption of free ATP (see
solid line in the inset). The BLM-associated-PI-4K activity was measured at the total
MgCl2 concentrations shown on the abscissa in a ﬁxed concentration of ATP 1 mM
and the other standard conditions described in Section 2.5. The smooth curve was
adjusted to the experimental points by non-linear regression using the equation BLM-
associated-PI-4K activity = Vmax × [MgCl2]n / {(K0.5 Mg)n + [MgCl2]n}. K0.5Mg = 4.7 mM is
the concentration of MgCl2 that gives half-maximal velocity (Vmax = 67.5 pmol ×
mg−1 × min−1) and n is a cooperativity index (1.85). Inset: variation in the concen-
trations of the MgATP2− complex and of free ATP with increasing MgCl2 concentra-
tions. C. Abscissa: BLM-associated-PI-4K activity/[MgATP2–]; ordinate: BLM-
associated-PI-4K activity. The straight line was adjusted to the data by least squares
using the equation BLM-associated-PI-4K = Vmax − b × [MgATP2−]. Values of Vmax =
65.9 pmol mg−1 × min−1 and Km MgATP = 24 μM were calculated from the y- and
x-intercepts, respectively. The concentrations of MgATP2− complex (1 mM total ATP, vary-
ing MgCl2 concentrations) were calculated as described in Material and Methods.
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formation of PtdIns(4)P that shows a linearity in the PI-4K activity within
the time range spanned in the assay (up to 10 min; Suppl. Fig. 1, top
panel). We also tested different protein concentrations (Suppl. Fig. 1,
bottom panel) as well as the temperature dependence and pH effect for
PI-4K activity. Suppl. Fig. 2 shows that the BLM-PI-4K activity gradually
increased from 17 °C reaching its maximal value at 37 °C (main panel).
The inset to Suppl. Fig. 2 shows that a single Arrhenius function adjusts
to the experimental points in the temperature interval 17–37 °C, with
an energy of activation value of 58.6 kJ × mol−1. The optimal pH for the
BLM-PI-4K activity was in the 6.9−7.1 range (Suppl. Fig. 3).
The functional characterization of a type II PI-4K was accomplished
through standard experiments. Fig. 1B shows that the BLM-PI-4K activ-
ity is highly sensitive to adenosine at a micromolar range (100 μM) and
completely insensitive to the PI-3K inhibitor wortmanin, (even if at
higher concentrations known to inhibit type III PI-4K (Fig. 1C)). Further-
more, Fig. 1D shows the increased concentrations of Ca2+ vastly inhibit
BLM-PI-4K at the micro molar range. These results in addition to the
molecular weight of the immunodetected protein (Fig. 1A, right
panel) clearly indicate that the enzyme in question is a Type II PI-4K as-
sociated to the BLM.
3.3. Substrate dependence for the BLM-PI-4K activity
PI-4K has two substrates (the phosphorylatable PtdIns and the phos-
phorylating ATP) and a cofactor (Mg2+). Fig. 2A shows that endogenous
BLM PtdIns is enough to promote the half maximal activation of the
enzyme in non-stimulated condition, and Fig. 2B and C show that the
true phosphorylating substrate is the Mg.ATP2− complex, since (i) the
BLM-associated-PI-4K activity increases (main panel in Fig. 2B) in paral-
lel with the raise in the concentration of Mg.ATP2− (see dashed line in
the inset) and (ii) the correlation of PtdIns(4)P formation vs BLM-
associated-PI-4K activity/[substrate] decreases according to Mg.ATP2−
complex consumption (Fig. 2C) (half maximal activation in the energy–
donor substrate curve was found at 24 μMMg.ATP2-). Moreover, Table 1
clearly shows that free ATP is an inhibitor of the enzyme, probably by
competition with the MgATP2− complex. When the kinetics of BL-PI-4K
activation is examined as a function of total MgCl2, a sigmoidal proﬁle is
obtained (Fig. 2B). The cooperativity of the total magnesium curve
(n ≈ 2) suggests that two sites for the cation are present in BLM-PI-4K.
3.4. Crosstalk between glycero- and sphingolipids in the BLM
In previous papers, we demonstrated reciprocal modulation of
glycero- and sphingolipids in the BLM [23,24]. Attenuation of the PA syn-
thesis was observed upon addition of sphingosine (Sph) in phosphoryla-
tion assays similar to those used here [24], and a ~3-fold stimulation of
PI-4K activity was detected with addition of 0.1 mM Sph or 0.4 μM
S132P [23]. In the present study we further characterized the inﬂuence
of Sph on the BLM-associated-PI-4K (Fig. 3). A ~3-fold augment in
BLM-associated-PI-4K activitywas detectedwith increasing Sph concen-
tration, up to 100 μM, followed by an apparent return to the basal
activity at higher concentrations (Fig. 3A). Under these higher Sph con-
centrations, a strong phosphorylation of Sph to sphingosine-1 phosphate
(S1P) occurs (Fig. 3B and as previously described in [23]-Fig. 3C). Inter-
estingly, the excitatory effect of Sph on BLM-PI-4K activity seems to be
independent of PtdIns levels, given that the addition of this substrate
promotes only slight additive effect on PtdIns(4)P generation, compared
with the endogenous lipid content (Fig. 3C).
4. Discussion
Phosphatidylinositol kinase activity has been reported to be present
in a variety of cellular membranes while different isozymes of PI-4K are
presentwithin the cell— suggesting that the product of its reactionmay
havemore than one biological function aswell as different mechanismsfor their regulation [5]. The detection of PI-4K activity associated to the
BLM has already been reported in previous work from our laboratory
[11,23,24]. Here, we added new insights and detailed biochemical char-
acterization of the BLM-associated-PI-4K function and regulation. The
Table 1
Free ATP inhibits BLM-associated-PI-4K activitya.
Total ATP (mM) MgATP2−/free ATP ratio PI-4K activity
(pmol × mg−1 × min−1)
0.7 5.0 44.9
1.0 3.2 32.7
1.5 1.6 24.0
2.0 1.0 14.9
5.0 0.3 9.0
a BLM-associated-PI-4K activitywasmeasured under the standard conditionsdescribed
in Material and Methods at the total [γ-32P]ATP concentrations shown. Free ATP and
MgATP2− concentrations (obtained with 1.1 mM MgCl2 and varying the total ATP) were
calculated as described in Material and Methods [29].
Fig. 3. BLM-associated-PI-4K activity is inﬂuenced by the presence of Sph and by its phos-
phorylated derivative S1P. A. PtdIns(4)P formation is activated by increasing concentra-
tion of exogenous Sph up to 100 μM. The BLM-associated-PI-4K activity was performed
as described in Section 2.5, without and with exogenous Sph, as depicted in the abscissa.
Results are expressed as mean ± SEM of four different experiments done in triplicate.
B. Increased S132P synthesis in BLM preparation incubated with a high μM range of exog-
enous Sph (from 300 to 500 μM). Phosphorylation assays and lipid extraction were con-
ducted as described in Sections 2.3 and 2.4. S132P and PtdIns(4)32P formation were
measured in the same assays carried out with increasing concentrations of Sph, as
shown in the abscissa. Results expressed as means ± SEM from four different experi-
ments done in triplicate (n = 4). * Statistically different (p b 0.01). C. The BLM-
associated-PI-4K activity was performed as described in Section 2.5, without or with the
addition of exogenous PtdIns at 20 nM, or Sph at 100 μM, as depicted in the abscissa.
Results are expressed as mean ± SEM of four different experiments done in triplicate.
* Statistically different with p b 0.05; ** p b 0.01.
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to the type II PI-4K, which are known to be associated with plasma
membranes and were already puriﬁed from different sources with sim-
ilar molecular weight [14–16]. The KmMg.ATP found (24 μM) is also com-
patible with that described for type II PI-4K [3,14]. The existence of two
Mg2+ sites, revealed by the cooperativity of theMgCl2 curve (n = 1.85;
Fig. 2B) and supported by the observation that theMg.ATP2– complex is
the true energy-donor substrate at a KMg = 4.7 mM in the extracellular
concentration range, is compatible with a model in which BLM PI-4K
has a cytosolic active site (for the complex Mg.ATP2−) and a regulatory
site for free Mg2+ that faces the interstitial space.
The importance of phosphoinositides in cell signaling events of
the kidney has been studied for several years [32,33] and our
group showed evidences of glycero- and sphingolipids interaction
[24], especially activation of PI-4K by Sph [23]. In the present
study, detailed substrate characterization of the BLM-associated
PI-4K of proximal tubule cells is provided and for the ﬁrst time the
biphasic modulation of PI-4K by Sph is presented. Analyzing these
and our previous results [23], it is possible to hypothesize two
mechanisms of Sph-mediated PI-4K activity regulation. At ﬁrst, the
trade-off between PI-4K activity and S1P formation (Fig. 3A and B,
respectively) is suggestive of an antagonistic role of Sph and its
phosphorylated derivative: while Sph acts stimulating PtdIns(4)P
formation in BLM, higher availability of S1P inhibits this process.
The role of Sph on cell metabolism usually involves its action as an
intracellular messenger, modulating the activity of other important
cell signaling kinases, such as PKC. In addition, much of its physio-
logical effect seems to be counterbalanced (at least partially) by
the formation of S1P. The second potential mechanism accounting
for the biphasic effect of Sph on PI-4K relies on our previous results
showing an agonistic effect of BLM-derived S1P on PI-4K activity
(see Fig. 6 from [23]). In this hypothesis the enhancement of the
kinase's activity with 100 μM Sph could be due to the low level S1P
formation (note that increased activity of PI-4K in [23] was observed
with nanomolar levels of S1P). Conversely, higher levels of this
phophorylated sphingolipid could have the opposite effect on
PtdInd(4)P formation. Whatever the mechanism involved, the balance
between Sph/S1P level should be considered critical for regulation of
PI-4K activity in BLM of kidney cells.
The physiological relevance of PI-4K in BLMcan be directly associated
with ion transport across the renal epithelium, judging by themodulato-
ry effect of PtdIns(4)P on different plasma membrane ion transporters
and channels [9,11,12]. The generation of PtdIns(4)P in the BLM of prox-
imal tubule cells can also be important for other cell processes [34], as
well as being converted to PtdIns(4,5)P2 [35] or PtdIns(3,4)P2, which
are involved in a myriad of cellular events including ion transport
[13,36]. Different points of convergence among these distinct signaling
cascades can play important physiological roles in the BLM [23,37–40].
The ﬁrst product of PI-4K that is described here can be considered as
the ﬁrst messenger of the network that modulates relevant function in
these cells, such as the reabsorption of large amounts of ﬂuid.
PtdIns(4)P and PA are the only products simultaneously phosphory-
lated at picomolar stoichiometric amounts at the same rate at pH 7.0,
37 °C, 1 mM ATP and 1.1 mM MgCl2 (Supplementary material) sug-
gesting that PI-4K (presented here) and diacylglycerol kinase (DGK) ac-
tivities [24] are tightly coupled in BLM. This could also be important in
the regulation of transport events, since the substrate for DGK, the
DAGmolecule, is an activator of PKC, which in turn is a potent inhibitor
of Ca2+ transport [20,41] and an activator of Na+ transport [31,42].
Different thermal behavior of PI-4K and DGK (Fig. S3; compare
with Fig. 3 in [24]) and the contrasting response to Sph in conditions
in which the phosphorylated form of this sphingolipid prevails [23],
indicate that alterations in the neighboring lipid microenvironment
of the two glycerolipid kinases could be important in the balance of
PtdIns(4)P/PA within the renal membranes. The non-additive effects
of PtdIns and Sph on PI-4K activity (Fig. 3C) may indicate that the
1008 T. Lemos et al. / Biochimica et Biophysica Acta 1838 (2014) 1003–1009efﬁcient modulation triggered via sphingolipids can occur indepen-
dently of local PtdIns ﬂuctuation.
The opposite effect of Sph onDGK (see [24]) and BLM-PI4-K (present
study) deserve further mention due to their potential physiological
relevance. It can be hypothesized that under conditions in which
ceramidase activity and Sph release are stimulated above the normal
levels [43,44] with preservation of high DAG levels (as in the case of a
rise in circulating angiotensin II and concomitant activation of PLC
[41]) the stimulation of PtdIns(4)P formation by Sph (Fig. 3A) could
compensate for uncontrolled increase in intracellular Ca2+ in kidney
cells. Plasma membrane Ca2+-ATPase activity, which is considered re-
sponsible for ﬁne tuning cytosolic Ca2+ levels [45,46] can strongly
be stimulated by PtdIns(4)P [9,11], and could attenuate the DAG-
stimulated PKC inhibition of Ca2+-ATPase. Since the present work was
carried out in the absence of any agonist, it can be postulated that differ-
ent hormones and/or autacoids that are able to activate PKC, such as
adenosine and angiotensin II [20,41], are physiological cognates in the
modulation of PI-4K and in their associated regulatory networks in kid-
ney cells.
Thorough comprehension of the biochemical properties of these en-
zymes could lead to new drug development that would be aimed at
targeting the production of glycero- and sphingolipid-derived second
messengers inside kidney cells and thereby regulating the hydro- and
electrolytic balance of the kidney.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2013.12.007.Acknowledgments
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